Podcast

Cancer Care in the Age of COVID-19: Dr Patricia Salber Interviews Dr Bobby Reddy

Patricia Salber, MD, MBA, of The Doctor Weighs In, and Sandeep “Bobby” Reddy, MD, an oncologist at Harbor-UCLA Medical Center and chief medical officer of NantHealth, discuss the clinical care of patients with cancer in the age of COVID-19.

While there remain a lot of unknowns about coronavirus disease 2019 (COVID-19) and the risk of infection facing patients with cancer, it is known that when they do contract the virus, they are at a higher risk of mortality, explained Sandeep “Bobby” Reddy, MD, an oncologist at Harbor-UCLA Medical Center and chief medical officer of NantHealth, during an interview with Patricia Salber, MD, MBA, of The Doctor Weighs In.

Reddy discussed the clinical care of patients with cancer in the age of COVID-19, including how care has changed as a result of the pandemic; best practices at treatment centers to protect patients and staff; recommendations for patients, whether they are in the middle of treatment, haven’t yet started treatment, or have discovered something worrisome but haven’t yet been diagnosed; and more.

Listen above or through one of these podcast services:

iTunes

Spotify

TuneIn

Stitcher

Read about related stories:

Diagnostic Delays From COVID-19 May Increase Cancer-Related Deaths, UK Studies Say

COVID-19 and Cancer: NCI's Sharpless Says COVID-19 Could Halt Streak of US Cancer Mortality Gains

Continuation of Routine Screenings, Care Is Crucial During COVID-19 Pandemic

Don't Delay Cancer Care During COVID-19 Crisis

Related Videos
Parth Rali, MD
1 KOL is featured in this series.
4 KOLs are featured in this series
4 KOLs are featured in this series
Screenshot during an interview with Aaron Adkisson, PharmD
Benjamin Scirica, MD, MPH, associate professor of medicine at Harvard Medical School and director of quality initiatives at Brigham and Women’s Hospital’s Cardiovascular Division
Laurence Sperling, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo